30 April 2026
Drug prices in Malaysia haven’t risen yet, but increases are expected as higher API costs feed through, says MAPS. Heavy reliance on imported API exposes Malaysia’s medicine supply to shocks, though delays haven’t caused nationwide shortages yet.